Please use this identifier to cite or link to this item:
|Title:||Tyrosine kinase inhibitors: A new approach for asthma||Authors:||Wong, W.S.F.
Immunoreceptor tyrosine-based activation motifs
Tyrosine kinase inhibitor
|Issue Date:||2004||Citation:||Wong, W.S.F., Leong, K.P. (2004). Tyrosine kinase inhibitors: A new approach for asthma. Biochimica et Biophysica Acta - Proteins and Proteomics 1697 (1-2) : 53-69. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bbapap.2003.11.013||Abstract:||The pathogenesis of allergic asthma involves the interplay of inflammatory cells and airway-resident cells, and of their secreted mediators including cytokines, chemokines, growth factors and inflammatory mediators. Receptor tyrosine kinases are important for the pathogenesis of airway remodeling. Activation of epidermal growth factor (EGF) receptor kinase and platelet-derived growth factor (PDGF) receptor kinase leads to hyperplasia of airway smooth muscle cells, epithelial cells and goblet cells. Stimulation of non-receptor tyrosine kinases (e.g. Lyn, Lck, Syk, ZAP-70, Fyn, Btk, Itk) is the earliest detectable signaling response upon antigen-induced immunoreceptor activation in inflammatory cells. Cytokine receptor dimerization upon ligand stimulation induces activation of Janus tyrosine kinases (JAKs), leading to recruitment and phosphorylation of signal transducer and activator of transcription (STAT) for selective gene expression regulation. Activation of chemokine receptors can trigger JAK-STAT pathway, Lck, Fyn, Lyn, Fgr, and Syk/Zap-70 to induce chemotaxis of inflammatory cells. Inhibitors of tyrosine kinases have been shown in vitro to block growth factor-induced hyperplasia of airway-resident cells; antigen-induced inflammatory cell activation and cytokine synthesis; cytokine-mediated pro-inflammatory gene expression in inflammatory and airway cells; and chemokine-induced chemotaxis of inflammatory cells. Recently, anti-inflammatory effects of tyrosine kinase inhibitors (e.g. genistein, tyrphostin AG213, piceatannol, tyrphostin AG490, WHI-P97, WHI-P131, Syk antisense) in animal models of allergic asthma have been reported. Therefore, development of inhibitors of tyrosine kinases can be a very attractive strategy for the treatment of asthma. © 2003 Elsevier B.V. All rights reserved.||Source Title:||Biochimica et Biophysica Acta - Proteins and Proteomics||URI:||http://scholarbank.nus.edu.sg/handle/10635/32206||ISSN:||15709639||DOI:||10.1016/j.bbapap.2003.11.013|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 13, 2020
WEB OF SCIENCETM
checked on Feb 13, 2020
checked on Feb 5, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.